Cargando…

Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis

BACKGROUND: This study investigated potential prognostic factors in patients treated with whole-brain irradiation (WBI) alone for brain metastases from relatively radioresistant tumors such as malignant melanoma, renal cell carcinoma, and colorectal cancer. Additionally, a potential benefit from esc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyners, Thekla, Heisterkamp, Christine, Kueter, Jan-Dirk, Veninga, Theo, Stalpers, Lukas JA, Schild, Steven E, Rades, Dirk
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988027/ https://www.ncbi.nlm.nih.gov/pubmed/20977700 http://dx.doi.org/10.1186/1471-2407-10-582

Ejemplares similares

A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases
por: Rades, Dirk, et al.
Publicado: (2017)

The prognostic value of tumor necrosis in patients undergoing stereotactic radiosurgery of brain metastases
por: Martens, Kristina, et al.
Publicado: (2013)

A matched-pair analysis comparing whole-brain radiotherapy with and without a stereotactic boost for intracerebral control and overall survival in patients with one to three cerebral metastases
por: Rades, Dirk, et al.
Publicado: (2017)

Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer
por: Rades, Dirk, et al.
Publicado: (2014)

The First Survival Score for Patients Aged ≥80 Years Irradiated for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2022)

Comparison of Diagnosis-Specific Survival Scores for Patients with Small-Cell Lung Cancer Irradiated for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2019)

Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases
por: Rades, Dirk, et al.
Publicado: (2019)

Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?
por: Rades, Dirk, et al.
Publicado: (2014)

A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer
por: Rades, Dirk, et al.
Publicado: (2012)

A scoring system to predict local progression-free survival in patients irradiated with 20 Gy in 5 fractions for malignant spinal cord compression
por: Rades, Dirk, et al.
Publicado: (2018)

An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer
por: Rades, Dirk, et al.
Publicado: (2020)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023)

Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy
por: Rades, Dirk, et al.
Publicado: (2022)

The Usefulness of Stereotactic Radiosurgery for Radioresistant Brain Metastases
por: Kim, Hyool, et al.
Publicado: (2013)

1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups
por: Rades, Dirk, et al.
Publicado: (2018)

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses
por: Rades, Dirk, et al.
Publicado: (2015)

Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases
por: Janssen, Stefan, et al.
Publicado: (2019)

A new prognostic instrument to predict the probability of developing new cerebral metastases after radiosurgery alone
por: Huttenlocher, Stefan, et al.
Publicado: (2014)

A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression
por: Rades, Dirk, et al.
Publicado: (2016)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023)

Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases
por: Sayan, Mutlay, et al.
Publicado: (2019)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
por: El Shafie, Rami A., et al.
Publicado: (2020)

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

An Easy-To-Use Survival Score Compared to Existing Tools for Older Patients with Cerebral Metastases from Colorectal Cancer
por: Rades, Dirk, et al.
Publicado: (2020)

Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer
por: Tallet, Agnes V., et al.
Publicado: (2014)

Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer
por: Rades, Dirk, et al.
Publicado: (2020)

Radioresistance of Brain Tumors
por: Kelley, Kevin, et al.
Publicado: (2016)

TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases
por: Choi, Seung Ho, et al.
Publicado: (2014)

Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both
por: El Gantery, Mahmoud M, et al.
Publicado: (2014)

A New Survival Score for Patients ≥65 Years Assigned to Radiotherapy of Bone Metastases
por: Rades, Dirk, et al.
Publicado: (2022)

CD44‐associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage
por: Liu, Wei‐Hsiu, et al.
Publicado: (2019)

A New Instrument for Predicting Survival of Patients with Cerebral Metastases from Breast Cancer Developed in a Homogeneously Treated Cohort
por: Janssen, Stefan, et al.
Publicado: (2019)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice
por: Verhoeff, Joost JC, et al.
Publicado: (2007)

Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
por: Rojas-Puentes, Luis L, et al.
Publicado: (2013)

Early Identification of Pneumonitis in Patients Irradiated for Lung Cancer—Final Results of the PARALUC Trial
por: Rades, Dirk, et al.
Publicado: (2023)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
por: Lesueur, Paul, et al.
Publicado: (2018)

Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports
por: Négrier, Sylvie, et al.
Publicado: (2018)

Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer
por: Okada, Yukinori, et al.
Publicado: (2020)

A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer
por: Rades, Dirk, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6ji252tt1tvseiqqop8ohhumq8